Delivery Order SPE2DX22D0010-SPE2D825FJD10
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,197.66 to AmerisourceBergen Drug Corp on August 9, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,742.76 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,394.30 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, valued at $21,749.88, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the company's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $87,605.42 to AmerisourceBergen Drug Corp on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,087.20 to AmerisourceBergen Drug Corp on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $33,531.40 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The company, headquartered in Conshohocken, Pennsylvania, will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,040 to AmerisourceBergen Drug Corp on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order, issued under contract number 4569466091, represents a non-set-aside competitive award to supply pharmaceutical products and medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $40,227 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJD10Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,038.61 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's prime IDC vehicle valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support contract enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition and its extensive portfolio of medical product deliveries for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.0k | 9/5/25 |